Vol.

THROMBOSIS RESEARCH Printed in the United

THE EFFECT

OFDEXTRAN

States

ON COLLAGEN-INDUCED

6, pp. ,409~420,

1975

Pergamon

Inc.

Press,

PLATELET AGGREGATION

IN VITRO S . Bygdeman and 0.

Department of Clinical

Physiology,

at the Serafimer Hospital, Biochemical

Research,

(Received

Tangen

Karolinska Institutet

Stockholm and Department of

Pharmacia AB , Uppsala,

20.12.1974;

Accepted

Sweden

in revised form 12.3.1975. by Editor B. Blomb'rick)

ABSTRACT Dextran was shown to potentiate platelet aggregation induced by acid soluble collagen in vitro. Both the extent of aggregation and the lag time were influenced by dextmn. In contMst, platelet aggregation induced by suspensions of insoluble collagen was not affected by dextmn. Further experiments using a turbidimetric technique demonstrated that the rate of precipitation of collagen fibres from tropocollagen was enhanced in the presence of dextmn. This effect could be demonstmted both in salt solutions and in plasma. It is proposed that the potentiation by dextran on platelet aggregation induced by acid soluble collagen can be explained by the increased rate of collagen fibre formation in the presence of dextran.

INTRODUCTION Dextran has an antithrombotic by dextran-induced

effect,

which at least partly has been explained

inhibition of the platelet retention and aggregation

tion (1) and inhibition of platelet thrombus formation in viva (2,3). hibitory effect observed

of dextran on platelet retention and aggregation

following

infusions

of dextran,

ted that the effect of dextmn infusions one or more plasma factors necessary than to an effect on the platelets However,

The in-

is mainly

and we therefore originally

sugges-

could be due to an interference for normal platelet responses

themselves

reac-

with

rather

(1).

in recent years it has been suggested

that dextran can directly

modify platelet function in vitro , and that these effects

also might explain

PLATELET

410

the antithrombotic

AGGREGATION

effect of dextmn in vivo. Thus, it has been shown that in-

cubation of human platelet rich plasma (PRP) with dextran in vitro can induce a limited degree of platelet aggregation

(4). Gordon and Evans (5) have re-

ported that when titrated pig and rabbit PRP containing

dextran was continuous-

ly rotated for up to 150 minutes,

followed

an initial potentiation

sive inhibition of the aggregation Small platelet aggregates taining dextran. aggregates

response

to ADP and collagen

were occasionally

It was proposed that the formation of small transient platelet

further aggregating

of these platelets to

stimuli could partially explain the antithrombotic

The mechanisms involved in dextran-induced

in vitro are not understood, condary to a release a facilitation in accordance

although it has been suggested

of adenosine

diphosphate

of the platelet release reaction with some other findings

(51, These hypotheses

situations

in man

of dextran on platelet funcresponse

induced by

preparation to human and rabbit PRP was

In the present investigation,

the mechanism of the

has been studied with respect to type of collagen

of dextran on collagen

use of

and we have therefore

that the platelet aggregation

addition of an acid soluble collagen potentiated by dextran.

effects

(6) or

are not

In view of the extensive

the mechanism of action is not without importance, tion in vitro. We discovered

to be either se-

(ADP) from the platelets

(1,7).

attempted to further evaluate the possible

effect

platelet aggregation

dextran in the prevention of thrombosis in different clinical

potentiation

was observed

seen in rotated samples con-

in moving blood followed by refractoriness

of dextran.

by a progres-

used and effect

fibre formation in vitro. METHODS

Platelet aggregation

was studied using either venous blood obtained from

healthy human volunteers

or arterial blood taken from rabbits through a

catheter inserted in the carotid artery under light pentobarbitone

anaesthesia.

The blood was collected

l/lOth

into siliconised

glass tubes containing

vo-

lume of 3.13 per cent trisodium citrate dihydmte. PRP was prepared 30 minutes after blood collection blood at 2 90 x g for 15 minutes at room temperature. plasma (PPP) the platelet rich plasma was centrifuged tes.

Platelet aggregation

in response

by centrifuging

To obtaine platelet poor at 1200 x g for 20 minu-

to standard amounts of collagen

and

adenosine

diphosphate

according

to the turbidimetric method of Born (81. Three types of collagen

preparations were used,

(ADP) was determined at 33’C

whole

namely acid soluble collagen

or room temperature obtained from Stago

411

PLATELET AGGREGATION

vo1.6,No.5

Laboratories

(France) and Sigma Chemical Co.

(St. Louis) and an insoluble

preparation from Sigma Chemical Co. The collagen

collagen

ratories was used in the experiments

in Figs.

from Stago Lab+

1 and 2. Collagen

Chemical Co. was used for all other experiments.

The soluble

from Sigma collagen

pre-

parations were solved in 0.1 N acetic acid pH 3.5 and diluted with THAMbuffered saline before use. buffered saline according ments THAM-buffered

The insoluble

was suspended

in THAM-

to Evans et al. (9) before use. In control experi-

saline was added instead of dextran.

ADP (Sigma Chemical Co.) and dissolved

collagen

400 ug/ml was prepared as a stock solution

in THAM-buffered

saline.

The solution was frozen in portions,

mixed, and diluted before use. A photometric technique was used to study the rate of collagen tate formation.

Aliquots of collagen

red saline or PPP in absence

were added to cuvettes

or presence

of dextran.

in a Vitatron photometer Model UC 200 connected

precfpi-

containing

The cuvettes

buffe-

were placed

to a Vitatron lin-log

recor-

der. The mixtures were stirred by magnetic stirrers and the temperature in the cuvette maintained at 33’C.

Changes in optical density with time could

thus be recorded and gave a relative measure of the rate of collagen

preci-

pitation. Three dextran fractions with a molecular weight of 40,000, 500,000

70,000 and

were used and referred to in the text as dx 40, dx 70 and dx 500 re-

s pectively . RESULTS The effects shown in Figs. potentiated

of dextran on collagen-induced l-4.

are

Addition of dx 40 and 70 to human titrated PRP markedly

the aggregation

reaction induced by acid soluble collagen

Stago Lab. (Fig. 1). All differences

between the dextmn-containing

and the appropriate controls were significant level.

platelet aggregation

from samples

at least at the one per cent

The potentiation was largely independent of the dextran fraction used,

Similar results were also obtained in a pilot study utilising dx 500. The degree of aggregation

was dependent on temperature,

red also at room temperature. ween addition of collagen decreased

significantly

was independent

Similarly,

but potentiation

occur-

the lag time, that is the time bet-

to the PRP-sample and the onset of the aggregation,

(pd 0.01) as seen in Fig. 2. The decrease

in lag time

of the molecular weight of the dextran preparation and could

be demonstrated both at room temperature and at 33’C.

C 4D”o C

Fig. 1

ID

70

Dx

6

70

cE cDx

d il

22 OC

fSE

.

Effects of dx 40 and 70 in a final concentration of 1.2 % on human platelet aggregation induced by addition of SO.pg/ml of an acid soluble collagen solution. C = control experiment. Normal saline added instead of dextran. Mean values of 5-7 experiments

0

0.05-

O.lO-

1

33Oc

A OD/15set

70

Fiu. 2,

sl c4D”o cDx

40

C Dx

22 OC T

Effect of dx 40 and 70 in a final concentration of 1.2 % on the lag time between addition of 50 ug of acid soluble collagen to PRP and the onset of the platelet aggregation reaction. C = control experiments. Normal saline added instead of dextran. Mean values of 5-7 experimens f SE.

0,

100,

200

300

400,

500

600

set

Lag time,

3 r .

twm’

25

soluble

Fig. 3,’

13

Acid

50

Collagen

200

p’/m’

100

Effect of dx 70 in a final concentration of 1.2% on human platelet aggregation induced by 13-50 pg/ml of acid soluble collagen solution or 100-200 ug/ml of an insoluble collagen preparatian. C = control experiments. Normal saline added instead of dextran. Mean values of 5-7 experiments k SE.

0.05

0.10

0.15

AOD/l!Wc

Fls. 4.

25 PgP

cb&

50

CR

loo 200 pVml

70

CL33 CDX

Suspension

Effect of dextran 70 in a final concentration of 1.2% on lag time between addition of different concentrations of an acid soluble collagen solution or different amounts of insoluble collagen preparation, C = control experiments. Normal saline adde$ instead of dextran. Mean values of 5-7 experiments - SE.

13

cog

Acid soluble

Collagen

PLATELET AGGREGATION

414

A significant

potentiation

of collagen-induced

also be demonstrated when a more effective

Vo1.6,No.5

platelet aggregation

acid soluble collagen

could

preparation

obtained from another manufacturer was used (Sigma Chemical Co.).

In this

series of experiments

and it

different concentrations

of collagen

was used,

could be shown that the potentiation was most marked with small concentrations of collagen

(Figs.

platelet aggregation when an insoluble

3-4).

Only a small change of collagen-induced

could be observed collagen

following

suspension

was used (Figs.

the fact that in control experiments this collagen lar degree of aggregation ved with a collagen

as the acid soluble

suspension

response

were compared.

soluble

collagen

preparation induced a simi-

preparation.

The lag time obser-

when dosages

giving the same

Here, the lag time was not significant-

ly changed (p > 0.05) by preincubation In 11 experiments

3-41, in spite of

was in control experiments markedly shorter

than that found with acid soluble collagen aggregation

incubation with dextran

with dx 40 and 70.

(no included in the figures) a concentration

too small to induce an aggregation

response

of acid

in control ex-

periments was used. After addition of dx 40, 70 and 500 to final plasma concentrations

of 1.2 per cent the same amounts of collagen

ficant aggregation

now induced a signi-

reaction in 9 of the 11 experiments.

Addition of dx 40 and 70 to PRP induced no change or a slight inhibition of ADP-induced potentiation

platelet aggregation

be observed

(0.05 4 p (

0.10).

In no case could a

(Table I). TABLEI

,Effect of Dextran on First Phase of ADP-Induced Platelet Aggregation at Room Temperature. ADP-dose 0.2 pg/ml. In control experiments 0.154 m NaCl was added instead of dextran . Type and concentration of dextran

Change in O.D./lS

No dextran

0.085 + 0.017

dx40

0.068 + 0.018

1.2%

dx 70 1.2 %

set’)

0.069 + 0.019

1) The results are expressed as the arithmetic means f S . D. of 9 measurements.

PLATELET

AGGREGATION

415

TABLEII Effect of Dextran on the Precipitation of Collagen in THAM Buffer-Saline Mixture. Precipitation mixture was 2.2 ml 0.154 M THAM-buffer, pH 7.4, 0.3 ml 0,154’ M ‘NaCl, 0.3 ml 0.154 M NaCl or desired concentrations of dx 7 0 in saline, and 0.2 ml of 2 mg/ml of collagen preparation dissolved in HAC 0.1 N or suspended in saline. Concentration of dx 70 in %

Type of collagen

Increase in O.D. l’ after 10 min after 30 min

Acid soluble

0

0.006 + 0.004

0.032 + 0.021

Acid soluble

1.2

0.053 + 0.025

0.110 + 0.056

Collagen

suspension

0

0.004 + 0.005

0.008 -I 0.009

Collagen

suspension

1.2

0.018 + 0.005

0.028 + 0.011

1) The results are expressed as the arithmetic mean + S. D. of separate experiments.

In Table II is shown that dx 70 significantly acid soluble collagen

in a salt solution.

found when the collagen collagen

suspension

enhanced

precipitation

of

No comparable change in O.D.

was

was used instead of the acid soluble

solution.

The results summarized in Tables III, IV and V demonstMte that the same effect

of dextran was obtained also when added to human or rabbit PPP. The

effect

of dextran was independent on molecular weight in the range of 40,000

to 500,000

Mw. TABLBIII

Effect of Dextran on the Precipitation of Collagen in Human PPP. The experimental conditions were similar to those described in Table II although PPP was used instead of THAM-buffer. Type of collagen

1)

Concentration of dx 70 in %

Increase in O.D. I1 after 10 min

Acid soluble

0

0.0054 + 0.0030

Acid soluble

1.2

0.0300 2 0.0100

Collagen

suspension

0

0.0034

Collagen

suspension

1.2

0.0032 + 0.0006

+ 0.0011

The results are expressed as the arithmetic means 2 S .D. of four separate experiments.

416

PLATELET

AGGREGATION

vo1.6,No.5

TABLEIV Effect of Dextran on the Precipitation of Acid Soluble Collagen Experimental conditions see Table III. Type and concentration of dextran

1) ~~ Increase in O.D. after 10 min after 30 min

No dextran

0.004 + 0.004

0.006 + 0.005

dx40

0.3%

0.018 + 0.021

0.040 2 0.044

II

0.6 %

0.025 + 0.016

0.040 + 0.016

II

1.2 %

0.039 + 0.023

0.053 + 0.024

II

2.0 %

0.039 + 0.009

0.051 + 0.021

0.3%

0.007 + 0.006

0.020 + 0.014

II

0.6 %

0.016 + 0.007

0.031+

,I

1.2 %

0.021:

0.010

0.042 + 0.024

II

2.0 %

0.044 + 0.025

0.076 2 0.019

dx 500

0.3 %

0.025 + 0.021

0.062 + 0.068

1,

0.6 %

0.032 + 0.041

0.057 2 0.030

II

1.2 %

0.054 + 0.051

0.091 : 0.090

II

2.0 %

0.054 -I 0.034

0.091+

dx70

in Rabbit PPP.

0.019

0.059

1) The results are expressed as the arithmetic means -+ S.D. of five separate experiments.

TABLEV Effect of Dextran on Precipitation of Collagen Experimental conditions see Table III.

Type and concentration of dextran

Increased after 10 min

Suspensions

in Rabbit PPP.

in 0. D. ‘) after 30 min

No dextran

0.001 + - 0.002

0.007 f 0.010

dx 40

0.6 %

0.005 2 0.004

0.018 + 0.011

dx 40

2.0 %

0.011+

0.013

0.024 + 0.030

dx 70

0.6 %

0.007 + 0.010

0.035 2 0.050

dx 70

2.0 %

0.011 + 0.008

0.035 + 0.028

dx 500

0.6 %

0.004 + 0.002

0.015 + 0.004

dx 500

2.0 %

0.021 + 0.017

0.044 + 0.047

1) The results are expressed as the arithmetic means + - S.D. five separate experiments.

of

PLATELET

vo1.6,No.5

417

AGGREGATION

DISCUSSION The antithrombotic

action of dextran infusions

several of the many biological tion of ADP-induced rical charge

effects

of dextran as for instance the inhibi-

platelet retention and aggregation,

of the formed elements of blood,

sity , and the recently demonstrated effect 11). An alternative

is most likely related to

explanation

decrease

creased

to a platelet release

platelets

platelet reactivity

infusions

observed,

This aggregation

has been sugges-

of ADP. If transient platelet aggrega-

of dextmn this might explain the desince it is known thgt once aggregated

be explained

of dextran,

do not decrease

of an increased

to

in vitro based on the

amount of ADP in plasma following

incubation

of

removal of the platelets by centrifugation.

in an attempt to reproduce these findings (7), we found that after

preparation of PPP by centrifugation, platelets.

in doses sufficient

by plasma dilution (1). Paterson and Dhall (6) reported that

PRP with dextran and subsequent However,

In many

platelet numbers more than can

dextran could induce a release of ADP from platelets observation

stimuli (12).

speak against this hypothesis.

studies it has been shown that infusions platelet reactivity,

(1, 10 ,

that dextmn in vitro

are at least temporarily refractory to aggregating

In our view several observations decrease

of whole blood visco-

has been proposed by Dhall and Matheson (4)

can induce a small degree of aggregation. tion occurs in vivo following

of the elect-

on fibrin formation and 1ySis

and by Cordon and Evans (5) based on the observation ted to be secondary

increase

In no instances

nucleotides

the ADP in PPP was related to remaining

could we detect any release

of neither adenine

nor serotonin by dextran.

The present results demonstmte that dextran potentiates gation induced by acid soluble collagen.

platelet aggre-

This might be taken as an argument

for the theory that the platelets are modified so as to potentiate their release reaction.

However,

the finding that dextmn influences

also the mode) of collagen Recently,

evidence

not aggregate

fibre formation offers an alternative

has been presented that monodisperse

platelets,

and that microfibrils

gation can take place (13). In addition,

the effect

fibre formation.

lets.

tropocollagen

does

have to be formed before aggreinduced by soluble collagen

de-

Thus, the present results indicate that

of dextran on platelet aggregation

due to an effect on collagen

explanation.

Caen and Legrand (14) and Hugues

(15) have reported that platelet aggregation pend on the collagen

the Mte (and possibly

induced by soluble collagen

is

fibre formation and not to an effect on the plate-

This is also strongly supported by the experiments with collagen

PLATELET

418

suspensions,

Vo1.6,No.5

AGGREGATION

where dextran did not affect the platelet

ly that the initial potentiation

of platelet reactivity

Gordon and Evans (5) in circulating Neither our experimental any conclusions

aggregation.

to collagen

PRP can be explained

It is like-

observed by

in a similar way.

design nor our instrumentation allows us to draw

about the exact nature of the effect of dextran on the colla-

gen fibre fromation.

Therefore,

it is not possible

to state whether it is an

altered rate of fibre formation or a change in fibre structure which is responsible for the potentiated platelet aggregation. dextran decreases

the solubility

of some proteins and that the phenomenon

seems to be due to a steric exclusion It is possible

instance

of the proteins by the dextran molecules,

that this may explain the effect of dextran on collagen

formation observed solubility

Laurent (16) has shown that

in the present study although the effect

of collagen fibrinogen

tration exceeds

has not been investigated

fibre

of dextran on the

and a precipitation

of for

in plasma seems only to occur when the dextran concen-

4-5 per cent.

lymer forming systems.

Dextran is also known to influence

The presence

other po-

of dextran has been shown to accele-

rate fibrin clot formation from fibrin monomers (lo),

and it has also been

shown that the structure of such fibrin is different from control fibrin (11). The two systems,

fibrin monomer

fibrin clot,

fibres are similar in several respects: the initial aggregation,

and tropocollagen

no covalent

bonds are produced during

both monomers are extremely asymmetrical molecules,

and the fibres formed have definite ordered structures. induces an increase

in absorbance

to formation of collagen gen microfibrils

of collagen

That dextran also

suspensions

may just be due

fibres from small amounts of tropocollagen

or colla-

presen In such preparations.

Very little is still known about the mechanism of dextran-induced let aggregation

collagen

in vitro.

However,

plate-

the results obtained in the present study

as well as earlier results (1,7) clearly demonstrate that dextran does not activate

human platelets

stances

like ADP and collagen

responsible

or portentiate platelet reactions fibers,

induced by sub-

which generally are thought to be

for the formation of platelet

aggregates

in viva.

ACKNCWLEDGMENTS This work was supported by a research grant from The Swedish Medical Research Council,

project no. 14X-1019.

PLATELET

vo1.6,No.5

419

AGGREGATION

REFERENCES 1.

BYGDEMAN , S. Prevention

with dextran.

Progr.

Surg.:

and thempy of thrombo-embolic I, 114. 1969.

complications

2.

BERMAN, H. J. and FULTON , G. P. Platelets in the peripheral circulation. latelets. S . A. Johnson, R .W. Monte, J.W. Rebuch and R. C . In: Blood &n-don, Churchill, 1961, P. 7.

3.

ARFORS, K.-E., DHALL, D.P., ENGESET, J., HINT, H., MATHESON, N. A. and TANGEN, 0. In vivo quantitation of platelet activity using biolaser-induced endothelial injury. Bibl. anat.: l0, 505. 1969.

4.

DHALL, D. P. and MATHESON, N.A. In vitro clumping of human by dextran. Thromb. Diath, Haemorrh. : l9, 70, 1968.

5.

GORDON, J. L. and EVANS, R. J. Dextran inhibition of platelet aggregation in vivo and in vitro. IVth Int. Congr. Thromb. Haemost. , Vienna 1973, 411.

6.

PATERSON, N. and DHALL, D. P .. The release of adenosine diphosphate 6th Europ. Conf . Microcircula(ADP) from human platelets by dextran. tion, Aalborg 1970, 324.

7.

, S. and TANGEN, 0. Studies on the antithrombotic effect of dextran. Effect on platelet 5-hydroxytryptamine and adenine nucleotides . 7th Europ. Congr. Microcirculation, Aberdeen 1972. Bibl. anat. : l2, 333. 1973.

8.

BORN, G. V. R. Quantitative platelets. J. Physiol. : 162,

9.

MUSTARD, J.F. and EVANS, G., PACKHAM, M.A., NISHIZAWA, E.E., MURPHY, E. The effect of acetylsalicylic acid on platelet function. J. Exptl Med.: 128, 877. 1968.

10.

of dextmn TANGEN, O., PHELAN III, W. J. and BERMAN, H. J. Influence and other macromolecules on thrombin time and the polymerization of fibrin monomer. XIII Int. Congr. Hematol. Munich 1970. Abstract 144.

11.

TANGEN, 0. , WIK, K. 0. , ALMQVIST, I.A. M. , ARFORS, K.-E. and HINT, H. C. Effect of dextran on the structure and plasmin-induced lysis of human fibrin. Thrombosis Res .: 1, 487. 1972.

12.

O’BRIEN, J.R. Changes in platelet membranes platelet stickiness. Nature: 212, 1057. 1966.

13.

MUGGLI

14.

CAEN, J. and LEGRAND, Y. Plaquettes, collagine concepts of coagulation and hemostasis . Thromb. 1971. Suppl. 48, 167.

platelets

BYGDEMAN

investigation 67. 1962.

into the aggregation

possibly

, R. and BAUMGARTNER , H.R. Collagen gation: Requirement for tropocollagen multimers. Thromb. Haemost. , Vienna 1973. Abstract 53.

of blood

associated

with

induced platelet aggreHIEG 73-82, IVth Congr. et elastine. In current Diath. Haemorrh, :

420

PLATELET

AGGREGATION

15. HUGUES, J. Some remarks concerning collagen, & Platelets in haemostasis. Exptl Biol. Med.: 3, 145. 1968.

v01.6,~0.5

platelet aggregation induced by S. Karger (Ed. 1 Base1 1968.

and other macro16. LAURENT, T. C . The interaction between polysaccharides molecules. The solubility of proteins in the presence of dextran. Biochem. J.: 89, 253. 1963.

The effect of dextran on collagen-induced platelet aggregation in vitro.

Vol. THROMBOSIS RESEARCH Printed in the United THE EFFECT OFDEXTRAN States ON COLLAGEN-INDUCED 6, pp. ,409~420, 1975 Pergamon Inc. Press, P...
760KB Sizes 0 Downloads 0 Views